Beyond Tumor Size, Toward Meaningful Patient Outcomes—Resisting RECIST
This Viewpoint evaluates the present relevance of Response Evaluation Criteria in Solid Tumors (RECIST) as cancer therapeutics have evolved beyond cytotoxic chemotherapy in assessing treatment outcomes.
Authors
- Vivek Subbiah (ORCID: https://orcid.org/0000-0002-6064-6837)
- Chadi Nabhan (ORCID: https://orcid.org/0000-0003-1740-299X)
Institutions
- University of South Carolina (US)
- Stanford Medicine (US)
- Stanford Cancer Institute
- Stanford University (US)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2026-10-08
- DOI
- https://doi.org/10.1001/jamaoncol.2026.3869
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00